mRNA - International Biopharmaceutical Industry

Current Edition

news

Pfizer’s big bet on mRNA, Biogen ‘proven wrong’ on Aduhelm price and the next cell therapies

Biotechnology stocks ended the first day of the J.P. Morgan Healthcare Conference in the green, but only barely. By Monday afternoon, a closely followed index of the ...

14 January 2022 news Alzheimer | cell

Continue Reading →

news

CureVac scales back mRNA manufacturing for coronavirus vaccine

While not acknowledged directly, the "corresponding changes in demand" could also stem from disappointing clinical trial results CureVac released for its vaccine in m...

17 September 2021 news coronavirus vaccine | CureVac

Continue Reading →

news

Merck, Moderna Expand mRNA Cancer Vaccines Partnership

On May 3, 2018, Merck and Moderna Therapeutics, a biotechnology company focused on messenger RNA (mRNA) drug discovery and drug development, announced an expansion of...

11 May 2018 news Expand | Merck

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Pfizer’s big bet on mRNA, Biogen ‘proven wrong’ on Aduhelm price and the next cell therapies

CureVac scales back mRNA manufacturing for coronavirus vaccine

Merck, Moderna Expand mRNA Cancer Vaccines Partnership

International Biopharmaceutical Industry